Clinical Trial: A Mobile App-Based Study to Evaluate Disease Burden and Treatment Patterns in Immunoglobulin A Nephropathy (IgAN) in the US

U.S., May 1 -- ClinicalTrials.gov registry received information related to the study (NCT06952426) titled 'A Mobile App-Based Study to Evaluate Disease Burden and Treatment Patterns in Immunoglobulin A Nephropathy (IgAN) in the US' on Feb. 26.

Brief Summary: The study aims to longitudinally capture the full spectrum of symptoms, treatment utilization, and overall health-related quality of life (HRQoL) experienced by Immunoglobulin A nephropathy (IgAN) patients and their caregivers.

Study Start Date: March 04

Study Type: OBSERVATIONAL

Condition: Immunoglobulin A Nephropathy

Intervention: OTHER: No intervention

Participants and their caregivers will report home reported outcomes (HRO) data on symptom burden to understand symptom varia...